Carcinoid tumor regression with high-dose octreotide acetate: a patient report

Am J Clin Oncol. 1998 Jun;21(3):246-7. doi: 10.1097/00000421-199806000-00007.

Abstract

A patient who had carcinoid tumor of the ileum and liver and intraabdominal lymph-node metastases sustained a substantial (more than 50%) reduction of metastatic tumor burden when treated with accelerated-dosage octreotide.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Carcinoid Tumor / drug therapy*
  • Carcinoid Tumor / secondary
  • Dose-Response Relationship, Drug
  • Humans
  • Ileal Neoplasms / drug therapy
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Lymphatic Metastasis
  • Male
  • Octreotide / administration & dosage*
  • Remission Induction
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents, Hormonal
  • Octreotide